Drug Search Results
Using advanced filters...
Advanced Search [+]

Norepinephrine

Alternative Names: norepinephrine, noradrenaline, levophed, noradrenalin, norepinefrina
Latest Update: 2025-04-07
Latest Update Note: News Article

Product Description

Norepinephrine, also called noradrenaline, is both a neurotransmitter and a hormone. As a neurotransmitter, it’s a chemical messenger that helps transmit nerve signals across nerve endings to another nerve cell, muscle cell or gland cell. As a hormone, it’s released by your adrenal glands, which are hat-shaped glands that sit on top of each kidney. (Sourced from: https://my.clevelandclinic.org/health/articles/22610-norepinephrine-noradrenaline)

Mechanisms of Action: SSR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Zhejiang University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Norepinephrine

Countries in Clinic: Brazil, Poland, Spain

Active Clinical Trial Count: 5

Highest Development Phases

Phase 3: Hypotension|Shock, Cardiogenic|Shock, Septic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NoVa

P3

Recruiting

Shock, Septic

2027-08-01

HYP-NOR

P3

Unknown Status

Hypotension

2027-06-30

CONTENTSS

P3

Unknown Status

Shock, Septic

2025-06-30

EPITUBE-HEART

P3

Active, not recruiting

Unknown

2023-02-20

Recent News Events